INMD - InMode Ltd.
NasdaqGS - NasdaqGS Real-time price. Currency in USD
At close: 04:00PM EDT
After hours:
Stock chart is not supported by your current browser
| Previous close | 32.10 |
| Open | 31.86 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 900 |
| Day's range | 31.17 - 31.92 |
| 52-week range | 21.20 - 41.84 |
| Volume | |
| Avg. volume | 1,276,926 |
| Market cap | 2.628B |
| Beta (5Y monthly) | 2.08 |
| PE ratio (TTM) | 15.86 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- CNW Group
InMode Receives Health Canada Certification of Forma-I for Dry Eye Disease Due to Meibomian Gland Dysfunction
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the Health Canada license of the Forma-I to address the symptoms of dry eye disease due to Meibomian gland dysfunction (MGD). Forma-I is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation.
